Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 30, 2012	Jan. 01, 2012	Jan. 02, 2011
Cash flows from operating activities:
Net income (loss)	$ 9,467	$ 9,875	$ (4,325)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	154,174	145,302	182,172
Loss on early extinguishment of debt	75,076	0	0
Distributions received from TimWen joint venture	15,274	14,942	13,980
Share-based Compensation, Including Portion Attributable to Discontinued Operations	11,473	17,688	13,704
Impairment of long-lived assets	21,097	14,441	69,477
Net (recognition) receipt of deferred vendor incentives	(920)	7,070	(587)
Accretion of long-term debt	7,973	8,120	15,016
Amortization of deferred financing costs	4,241	6,216	11,779
Non-cash rent expense	7,210	7,554	9,334
Loss on disposal of Arby's	442	8,799	0
Equity in earnings in joint ventures, net	(8,724)	(9,465)	(9,459)
Deferred income tax	(31,598)	1,624
Deferred Income Tax Expense (Benefit), Including Portion Attributable to Discontinued Operations			(29,779)
Operating investment adjustments, net	(27,769)	(145)	(5,201)
Other, net	3,093	2,999	8,264
Changes in operating assets and liabilities:
Accounts and notes receivable	3,999	(2,690)	(4,730)
Inventories	(561)	(517)	394
Prepaid expenses and other current assets	(1,360)	(7,580)	1,514
Accounts payable	(9,266)	11,364	(15,795)
Accrued expenses and other current liabilities	(42,906)	11,120	(29,508)
Net cash provided by operating activities	190,415	246,717	226,250
Cash flows from investing activities:
Capital Expenditures	(197,590)	(146,763)	(147,969)
Acquisitions	(40,608)	(11,210)	(3,123)
Franchise Loans, Net	3,092	(4,003)	0
Sale of Arby's, net	0	97,925	0
Dispositions	21,023	6,960	5,660
Investment activities, net	27,949	(841)	32,158
Other, net	(3,251)	(265)	352
Net cash (used in) provided by investing activities	(189,385)	(58,197)	(112,922)
Cash flows from financing activities:
Proceeds from long-term debt	1,113,750	0	497,661
Repayments of long-term debt	(1,044,310)	(38,702)	(474,791)
Deferred financing costs	(15,566)	(57)	(16,353)
Premium payments on redemption/purchase of notes	(43,151)	0	0
Repurchases of common stock	0	(157,556)	(173,537)
Dividends	(39,043)	(32,366)	(27,621)
Distribution to noncontrolling interests	(3,667)	0	0
Proceeds from stock option exercises	7,806	6,359	1,444
Other, net	52	(2,262)	(953)
Net cash used in financing activities	(24,129)	(224,584)	(194,150)
Net cash used in operations before effect of exchange rate changes on cash	(23,099)	(36,064)	(80,822)
Effect of exchange rate changes on cash	1,229	(1,213)	1,611
Net decrease in cash and cash equivalents	(21,870)	(37,277)	(79,211)
Cash and cash equivalents at beginning of year	475,231	512,508	591,719
Cash and cash equivalents at end of year	453,361	475,231	512,508
Investment activities, net:
Proceeds from repayment of DFR Notes	3,000
Cash paid during the period for:
Interest	110,701	111,675	127,753
Income taxes, net of refunds	10,124	13,588	14,262
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	22,109	23,767	14,985
Capital lease obligations	16,280	2,341	5,775
Indirect investment in Arby's	0	19,000	0
Operating Investment Adjustments, Net [Member]
Operating investment adjustments, net:
Operating investment adjustments, net	(27,769)	0	0
Other net recognized gains	0	(145)	(292)
Operating Investment Adjustments, Net [Member] | Gain on DFR Notes [Member]
Operating investment adjustments, net:
Income on collection of DFR Notes	0	0	(4,909)
Investment Activities, Net [Member]
Cash flows from investing activities:
Investment activities, net	27,949	(841)	32,158
Investment activities, net:
Proceeds from sale of investments	27,949	342	1,810
Proceeds from repayment of DFR Notes	0	0	30,752
Cost of securities	0	0	(404)
Investment in joint venture	$ 0	$ (1,183)	$ 0